Results 301 to 310 of about 128,641 (342)

Corticosteroid-induced manic and/or psychotic symptoms: a systematic review. [PDF]

open access: yesFront Pharmacol
Gostoli S   +5 more
europepmc   +1 more source

Emapalumab for Maladaptive Interferon‐γ‐Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First‐Line Antituberculosis Therapy

open access: yes
Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
Yahya Almodallal   +4 more
wiley   +1 more source

Guillain‐Barré Syndrome Disability Scale

open access: yes
Journal of the Peripheral Nervous System, Volume 30, Issue 4, December 2025.
Richard A. C. Hughes   +3 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of Methylprednisolone, Methylprednisolone Sodium Succinate, and Methylprednisolone Acetate in Dogs

Journal of Pharmaceutical Sciences, 1986
The absolute bioavailability and pharmacokinetic parameters of two methylprednisolone formulations (methylprednisolone sodium succinate and methylprednisolone acetate) were determined in five dogs. Plasma concentrations of methylprednisolone, methylprednisolone sodium succinate, and methylprednisolone acetate were measured by sensitive and specific ...
P.M. Fayolle   +3 more
openaire   +3 more sources

Hydrolysis of methylprednisolone hemisuccinate to methylprednisolone by a nonspecific carboxylesterase

Pharmacological Research Communications, 1980
Summary Enzymatic hydrolysis of methylprednisolone hemisuccinate with a non-specific carboxylesterase from hog liver was examined. The carboxyl-exterase was found to be useful in hydrolyzing methylprednisolone hemisuccinate to methylprednisolone.
T. Oshima, E. Nakajima, K. Hattori
openaire   +3 more sources

Pharmacokinetics of Methylprednisolone Hemisuccinate and Methylprednisolone in Chronic Liver Disease

The Journal of Clinical Pharmacology, 1993
The disposition of methylprednisolone (MP) and its prodrug hemisuccinate (MPHS) was assessed in six middle‐aged patients with chronic liver disease (CLD) and compared with six younger, healthy subjects after a single IV dose of 25.4 mg of MPHS. Blood and urine samples were collected over 12 hours.
Elizabeth A. Ludwig   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy